This is a Validated Antibody Database (VAD) review about Rhesus mon.. CD69, based on 47 published articles (read how Labome selects the articles), using CD69 antibody in all methods. It is aimed to help Labome visitors find the most suited CD69 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD69 synonym: early activation antigen CD69

BioLegend
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 4a
BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig 4a). Sci Rep (2019) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 5c
BioLegend CD69 antibody (Biolegend, 310906) was used in flow cytometry on human samples (fig 5c). Front Immunol (2019) ncbi
mouse monoclonal (FN50)
  • flow cytometry; mouse; loading ...; fig 5e
BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on mouse samples (fig 5e). Front Immunol (2018) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 4c
BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig 4c). PLoS Pathog (2018) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 5a, 5b
BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig 5a, 5b). Front Immunol (2018) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD69 antibody (BioLegend, 310932) was used in flow cytometry on human samples (fig 1b). JCI Insight (2018) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD69 antibody (BioLegend, 310910) was used in flow cytometry on human samples (fig 3a). Biol Reprod (2018) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig 1b). J Clin Invest (2018) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 7a
BioLegend CD69 antibody (BioLegend, 310906) was used in flow cytometry on human samples (fig 7a). Cell (2018) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 2f
BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on human samples (fig 2f). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 4b
BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig 4b). J Clin Invest (2017) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 3a
BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig 3a). Sci Rep (2017) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...
In order to investigate the effectiveness of a neoantigen vaccine against melanoma, BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on human samples . Nature (2017) ncbi
mouse monoclonal (FN50)
  • mass cytometry; human; loading ...; fig 2a
In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, BioLegend CD69 antibody (BioLegend, FN50) was used in mass cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 6c
In order to study the role of leukocyte antigen F in and antigen presentation and immune response, BioLegend CD69 antibody (BioLegend, 310930) was used in flow cytometry on human samples (fig 6c). Immunity (2017) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 1a
In order to detail MAIT cell responses to various microorganisms and cytokines, BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig 1a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD69 antibody (BioLegend, 310920) was used in flow cytometry on human samples (fig 2a). J Clin Invest (2017) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig 2a). elife (2017) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 1c
In order to study the differentiation of innate lymphoid cells, BioLegend CD69 antibody (Biolegend, 310930) was used in flow cytometry on human samples (fig 1c). Cell (2017) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig s2
BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on human samples (fig s2). Oncoimmunology (2017) ncbi
mouse monoclonal (FN50)
  • flow cytometry; Rhesus monkey; loading ...
In order to examine the kinetics of SIV-specific CD8+ T cell cytolytic factor expression in peripheral blood, lymph node, spleen, and gut mucosa from early acute infection through chronic infection, BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on Rhesus monkey samples . PLoS Pathog (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 2b
In order to characterize CD8 positive alpha beta gamma delta T cells, BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig 2b). J Immunol (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 1e
In order to investigate the role of Eomes in the retention of liver natural killer cells, BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig 1e). J Immunol (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 8a
In order to characterize CD8 positive T cell subsets in dengue patients from India and Thailand, BioLegend CD69 antibody (Biolegend, 310920) was used in flow cytometry on human samples (fig 8a). J Virol (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 5b
BioLegend CD69 antibody (Biolegend, 310910) was used in flow cytometry on human samples (fig 5b). Cell (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig s5
BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on human samples (fig s5). PLoS Pathog (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 1b
In order to ask if CD2 is involved in the response of adaptive natural killer cells to HCMV, BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig 1b). Eur J Immunol (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; Rhesus monkey; tbl 1
In order to characterize the role of T-cell depletion and macrophage polarization and infection during splenic damage during SIV infection, BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on Rhesus monkey samples (tbl 1). Am J Pathol (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; Rhesus monkey; loading ...; fig s3a
BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on Rhesus monkey samples (fig s3a). J Immunol (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig s9
In order to study the pharmacologic inhibition of PI3K and MEK pathways in mixed cultures of human mononuclear cells., BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig s9). Am J Transplant (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 2
BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on human samples (fig 2). J Virol (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 4
BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig 4). Int Immunol (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 5
BioLegend CD69 antibody (BD Biolegend, FN50) was used in flow cytometry on human samples (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 3d
In order to examine if pregnancy-related changes in disease activity are associated with changes in T cell populations, BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on human samples (fig 3d). Arthritis Res Ther (2016) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 1
BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
In order to optimize detection of IL-2 from live cells, BioLegend CD69 antibody (BioLegend, 310908) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
BioLegend CD69 antibody (Biolegend, 310925) was used in flow cytometry on human samples . Hum Immunol (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig s3
BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples (fig s3). J Immunol (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human; fig 7
BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on human samples (fig 7). Toxicol Sci (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on human samples . Eur J Immunol (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
In order to discuss how inflammation contributes to pulmonary arterial hypertension, BioLegend CD69 antibody (BioLegend, clone FN50) was used in flow cytometry on human samples . Chest (2015) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on human samples . Immunology (2014) ncbi
mouse monoclonal (FN50)
  • flow cytometry; human
In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BioLegend CD69 antibody (Biolegend, FN50) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (FN50)
  • flow cytometry; chimpanzee
In order to study the in vitro response of gammadelta T-cell subsets from HIV1-infected and control chimpanzees to T-cell activators, BioLegend CD69 antibody (BioLegend, FN50) was used in flow cytometry on chimpanzee samples . J Med Primatol (2014) ncbi
mouse monoclonal (FN50)
In order to assess the effect of delayed administration of the BCG vaccine on the induced immune response in Ugandan children, BioLegend CD69 antibody (Biolegend, FN50) was used . J Infect Dis (2014) ncbi
Bio-Rad
mouse monoclonal (FN50)
  • flow cytometry; human; loading ...; fig 1
In order to discuss the importance of assessing immune competence in cancer patients, Bio-Rad CD69 antibody (AbD Serotec, MCA 2806) was used in flow cytometry on human samples (fig 1). Cancer Immunol Immunother (2014) ncbi
Articles Reviewed
  1. Humeniuk P, Geiselhart S, Battin C, Webb T, Steinberger P, Paster W, et al. Generation of a Jurkat-based fluorescent reporter cell line to evaluate lipid antigen interaction with the human iNKT cell receptor. Sci Rep. 2019;9:7426 pubmed publisher
  2. Zimmermann M, Rose N, Lindner J, Kim H, Gonçalves A, Callegari I, et al. Antigen Extraction and B Cell Activation Enable Identification of Rare Membrane Antigen Specific Human B Cells. Front Immunol. 2019;10:829 pubmed publisher
  3. Hayashi T, Momota M, Kuroda E, Kusakabe T, Kobari S, Makisaka K, et al. DAMP-Inducing Adjuvant and PAMP Adjuvants Parallelly Enhance Protective Type-2 and Type-1 Immune Responses to Influenza Split Vaccination. Front Immunol. 2018;9:2619 pubmed publisher
  4. Ye W, Chew M, Hou J, Lai F, Leopold S, Loo H, et al. Microvesicles from malaria-infected red blood cells activate natural killer cells via MDA5 pathway. PLoS Pathog. 2018;14:e1007298 pubmed publisher
  5. Cooper G, Ostridge K, Khakoo S, Wilkinson T, Staples K. Human CD49a+ Lung Natural Killer Cell Cytotoxicity in Response to Influenza A Virus. Front Immunol. 2018;9:1671 pubmed publisher
  6. Watanabe K, Luo Y, Da T, Guedan S, Ruella M, Scholler J, et al. Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses. JCI Insight. 2018;3: pubmed publisher
  7. Warthan M, Washington S, Franzese S, Ramus R, Kim K, York T, et al. The role of endoplasmic reticulum aminopeptidase 2 in modulating immune detection of choriocarcinoma. Biol Reprod. 2018;98:309-322 pubmed publisher
  8. Pizzolla A, Nguyen T, Sant S, Jaffar J, Loudovaris T, Mannering S, et al. Influenza-specific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles. J Clin Invest. 2018;128:721-733 pubmed publisher
  9. Gee M, Han A, Lofgren S, Beausang J, Mendoza J, Birnbaum M, et al. Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes. Cell. 2018;172:549-563.e16 pubmed publisher
  10. Herndler Brandstetter D, Shan L, Yao Y, Stecher C, Plajer V, Lietzenmayer M, et al. Humanized mouse model supports development, function, and tissue residency of human natural killer cells. Proc Natl Acad Sci U S A. 2017;114:E9626-E9634 pubmed publisher
  11. Matos T, O Malley J, Lowry E, Hamm D, Kirsch I, Robins H, et al. Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing ?? T cell clones. J Clin Invest. 2017;127:4031-4041 pubmed publisher
  12. Lunemann S, Martrus G, Goebels H, Kautz T, Langeneckert A, Salzberger W, et al. Hobit expression by a subset of human liver-resident CD56bright Natural Killer cells. Sci Rep. 2017;7:6676 pubmed publisher
  13. Ott P, Hu Z, Keskin D, Shukla S, Sun J, Bozym D, et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature. 2017;547:217-221 pubmed publisher
  14. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed publisher
  15. Dulberger C, McMurtrey C, Hölzemer A, Neu K, Liu V, Steinbach A, et al. Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors. Immunity. 2017;46:1018-1029.e7 pubmed publisher
  16. Dias J, Leeansyah E, Sandberg J. Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines. Proc Natl Acad Sci U S A. 2017;114:E5434-E5443 pubmed publisher
  17. Watanabe R, Shirai T, Namkoong H, Zhang H, Berry G, Wallis B, et al. Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity. J Clin Invest. 2017;127:2725-2738 pubmed publisher
  18. Lepore M, Kalinichenko A, Calogero S, Kumar P, Paleja B, Schmaler M, et al. Functionally diverse human T cells recognize non-microbial antigens presented by MR1. elife. 2017;6: pubmed publisher
  19. Lim A, Li Y, Lopez Lastra S, Stadhouders R, Paul F, Casrouge A, et al. Systemic Human ILC Precursors Provide a Substrate for Tissue ILC Differentiation. Cell. 2017;168:1086-1100.e10 pubmed publisher
  20. Su S, Zou Z, Chen F, Ding N, Du J, Shao J, et al. CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer. Oncoimmunology. 2017;6:e1249558 pubmed publisher
  21. Roberts E, Carnathan D, Li H, Shaw G, Silvestri G, Betts M. Collapse of Cytolytic Potential in SIV-Specific CD8+ T Cells Following Acute SIV Infection in Rhesus Macaques. PLoS Pathog. 2016;12:e1006135 pubmed publisher
  22. Kadivar M, Petersson J, Svensson L, Marsal J. CD8??+ ?? T Cells: A Novel T Cell Subset with a Potential Role in Inflammatory Bowel Disease. J Immunol. 2016;197:4584-4592 pubmed
  23. Cuff A, Robertson F, Stegmann K, Pallett L, Maini M, Davidson B, et al. Eomeshi NK Cells in Human Liver Are Long-Lived and Do Not Recirculate but Can Be Replenished from the Circulation. J Immunol. 2016;197:4283-4291 pubmed
  24. Chandele A, Sewatanon J, Gunisetty S, Singla M, Onlamoon N, Akondy R, et al. Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India. J Virol. 2016;90:11259-11278 pubmed
  25. Roybal K, Williams J, Morsut L, Rupp L, Kolinko I, Choe J, et al. Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors. Cell. 2016;167:419-432.e16 pubmed publisher
  26. Pachnio A, Ciáurriz M, Begum J, Lal N, Zuo J, Beggs A, et al. Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium. PLoS Pathog. 2016;12:e1005832 pubmed publisher
  27. Rölle A, Halenius A, Ewen E, Cerwenka A, Hengel H, Momburg F. CD2-CD58 interactions are pivotal for the activation and function of adaptive natural killer cells in human cytomegalovirus infection. Eur J Immunol. 2016;46:2420-2425 pubmed publisher
  28. Williams D, Engle E, Shirk E, Queen S, Gama L, Mankowski J, et al. Splenic Damage during SIV Infection: Role of T-Cell Depletion and Macrophage Polarization and Infection. Am J Pathol. 2016;186:2068-2087 pubmed publisher
  29. Rueda C, Presicce P, Jackson C, Miller L, Kallapur S, Jobe A, et al. Lipopolysaccharide-Induced Chorioamnionitis Promotes IL-1-Dependent Inflammatory FOXP3+ CD4+ T Cells in the Fetal Rhesus Macaque. J Immunol. 2016;196:3706-15 pubmed publisher
  30. Zwang N, Zhang R, Germana S, Fan M, Hastings W, Cao A, et al. Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3-Kinase and MEK Pathways. Am J Transplant. 2016;16:2624-38 pubmed publisher
  31. Offersen R, Nissen S, Rasmussen T, Østergaard L, Denton P, Søgaard O, et al. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells. J Virol. 2016;90:4441-4453 pubmed publisher
  32. Setoguchi R. IL-15 boosts the function and migration of human terminally differentiated CD8+ T cells by inducing a unique gene signature. Int Immunol. 2016;28:293-305 pubmed publisher
  33. Su S, Hu B, Shao J, Shen B, Du J, Du Y, et al. CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients. Sci Rep. 2016;6:20070 pubmed publisher
  34. Tham M, Schlör G, Yerly D, Mueller C, Surbek D, Villiger P, et al. Reduced pro-inflammatory profile of γδT cells in pregnant patients with rheumatoid arthritis. Arthritis Res Ther. 2016;18:26 pubmed publisher
  35. Whisenant T, Peralta E, Aarreberg L, Gao N, Head S, Ordoukhanian P, et al. The Activation-Induced Assembly of an RNA/Protein Interactome Centered on the Splicing Factor U2AF2 Regulates Gene Expression in Human CD4 T Cells. PLoS ONE. 2015;10:e0144409 pubmed publisher
  36. Deng N, Mosmann T. Optimization of the cytokine secretion assay for human IL-2 in single and combination assays. Cytometry A. 2015;87:777-83 pubmed publisher
  37. Misra R, Shah S, Fowell D, Wang H, Scheible K, Misra S, et al. Preterm cord blood CD4⁺ T cells exhibit increased IL-6 production in chorioamnionitis and decreased CD4⁺ T cells in bronchopulmonary dysplasia. Hum Immunol. 2015;76:329-338 pubmed publisher
  38. Tsai C, Liong K, Gunalan M, Li N, Lim D, Fisher D, et al. Type I IFNs and IL-18 regulate the antiviral response of primary human γδ T cells against dendritic cells infected with Dengue virus. J Immunol. 2015;194:3890-900 pubmed publisher
  39. Phadnis Moghe A, Crawford R, Kaminski N. Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6. Toxicol Sci. 2015;144:39-50 pubmed publisher
  40. Setoguchi R, Matsui Y, Mouri K. mTOR signaling promotes a robust and continuous production of IFN-γ by human memory CD8+ T cells and their proliferation. Eur J Immunol. 2015;45:893-902 pubmed publisher
  41. Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed publisher
  42. Trinité B, Chan C, Lee C, Mahajan S, Luo Y, Muesing M, et al. Suppression of Foxo1 activity and down-modulation of CD62L (L-selectin) in HIV-1 infected resting CD4 T cells. PLoS ONE. 2014;9:e110719 pubmed publisher
  43. Vogel K, Thomann S, Vogel B, Schuster P, Schmidt B. Both plasmacytoid dendritic cells and monocytes stimulate natural killer cells early during human herpes simplex virus type 1 infections. Immunology. 2014;143:588-600 pubmed publisher
  44. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed publisher
  45. Hodara V, Parodi L, Chavez D, Smith L, Lanford R, Giavedoni L. Characterization of ??T cells in naïve and HIV-infected chimpanzees and their responses to T-cell activators in vitro. J Med Primatol. 2014;43:258-71 pubmed publisher
  46. Chang S, Kohrt H, Maecker H. Monitoring the immune competence of cancer patients to predict outcome. Cancer Immunol Immunother. 2014;63:713-9 pubmed publisher
  47. Lutwama F, Kagina B, Wajja A, Waiswa F, Mansoor N, Kirimunda S, et al. Distinct T-cell responses when BCG vaccination is delayed from birth to 6 weeks of age in Ugandan infants. J Infect Dis. 2014;209:887-97 pubmed publisher